Published in Gene Therapy Weekly, June 19th, 2008
"Neprilysin (NEP) is the dominant A beta peptide-degrading enzyme in the brain; NEP becomes inactivated and down-regulated during both the early stages of AD and aging. in this study, we investigated the effect of human (h)NEP gene transfer to the brain in a mouse model of AD before the development of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.